External Quality Controls

SARS Complete Panel

Respiratory Viral Panel

STI Panel

HPV Panel

Gastrointestinal Panel

ONBOARDx Kits

Proficiency Testing

Genital Ulcer Panel

DxTM Viral Transport Medium

Custom Vial Filling Solutions

Proudly Supporting Over 100+ Customers with Leading  Diagnostic Solutions 

Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™”

Gaetano Natale, Chief Commercial Officer.

The Microbix Difference

Our Quality Commitment

By choosing Microbix Biosystems Inc., you are aligning with a partner certified to the latest ISO standards and dedicated to delivering products that truly set the benchmark for quality in the industry.

Decades of Expertise

With over three decades of experience in the global diagnostics industry, Microbix has established a reputation as a leading infectious disease diagnostic manufacturer. 

Widespread Customer Acceptance

Microbix’s products have consistently earned widespread recognition and trust from customers due to their superior reliability. 

Download Our Full Product Catalogue 

News & Insights from Our Diagnostics Experts

  • Microbix Corporate Presentation — March 2024


  • Microbix’s Clot-Buster Drug Project Advances

    Sequel Pharma Executes Agreement with CDMO for Drug Substance Production MISSISSAUGA, CANADA, March 14, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its funding and commercialization partner, Sequel Pharma, LLC (“Sequel”), has executed, with support from Microbix, an agreement with a leading international contract…


  • Microbix Unveils Test Controls for Head and Neck Cancer

    HPV-related Tissue-Sample Mimics for QC of histology and PCR analyses MISSISSAUGA, CANADA, March 11, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of Quality Assessment Products (“QAPs™”) for supporting the quality control (“QC”) of histology and PCR-based tests driven by…


Speak to a Microbix Products Customer Service Representative

Let our knowledgeable experts help you secure your Microbix infectious disease diagnostics products supply today.